Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the relief of pain, inflammation, and fever associated with musculoskeletal disorders in horses.
INDICATIONS
Horses
- Arthritis and chronic arthrosis (e.g., in the hock, stifle, hip, and spine)
- Lameness resulting from soft-tissue injury or joint problems
- Laminitis (inflammation of the laminae of the hoof)
- Bursitis and capsulitis
- Myositis and muscle soreness
- Tendinitis and tenosynovitis (inflammation of tendons and tendon sheaths)
- Sprains, strains, and other painful injuries to limbs and joints
Dogs
- Osteoarthritis and other arthritic diseases
- Painful conditions of the musculoskeletal system, including posterior paralysis associated with intervertebral disc syndrome
- Bursitis and inflammation of ligaments
- Acute uveitis and injuries to the cornea/eyeball (in some regions)
Dosage and Duration: dosage based on the animal’s weight and condition. IV administration is typically limited to a maximum of 2 to 5 consecutive days, after which oral forms (paste, powder, or tablets) may be used for long-term therapy if needed.
ADMINISTRATION
- Route of Administration: Strictly intravenous only.
- Technique: The injection should be given slowly and with great care to prevent any of the medication from getting outside the vein into surrounding tissues.
- Duration: Intravenous administration is typically limited to a maximum of 5 consecutive days, after which oral forms of the medication may be used if long-term therapy is needed.
- Monitoring: The animal’s response should be prompt, usually within 24 hours. If there is no significant improvement after a certain period determined by the veterinarian, the diagnosis should be reevaluated.
